The prognostic value of myeloid derived suppressor cell level in hepatocellular carcinoma: A systematic review and meta-analysis
Authors:
Open Access
- 2 December 2019
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (12) , e0225327
Abstract
Many studies have investigated the association between the level of myeloid derived suppressor cells (MDSCs) and clinical features and prognosis of hepatocellular carcinoma (HCC), but the results remain controversial. This systematic review and meta-analysis was conducted to summarize all available data and estimate the relationship. A comprehensive literature review was carried out using Medline, Embase and Web of Science database through December 2018 to identify relevant studies. The standardized mean difference (SMD) and the hazard ratio (HR) with 95% confidence interval (CI) were utilized for evaluating continuous outcomes and survival analysis, respectively. All statistical analyses were performed by STATA 14.0 software. A total of 13 studies with 1002 HCC patients were included in the meta-analysis. Overall, the proportion of MDSCs in HCC patients was higher than that in healthy controls (SMD = 4.49, 95% CI = 2.53–6.46, PPP = 0.119). Moreover, increased MDSCs level was significantly associated with poorer overall survival (HR = 2.36, 95% CI = 1.70–3.29, PP<0.001), but not significantly correlated with any clinicopathological parameters. The results of this systematic review suggest that elevated MDSCs level appears to be associated with an increased risk for disease progression and poor prognosis for HCC.Keywords
Funding Information
- Chinese Foundation for Hepatitis Prevention and Control-TianQing Liver Disease Research Fund (TQGB20150231)
- Natural Science Foundation of Hebei Province of China (H2015106081)
- Hebei Medical Research Foundation (20150893)
This publication has 36 references indexed in Scilit:
- Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpectedJournal of Clinical Investigation, 2015
- Myeloid-Derived Suppressor Cells2015
- Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosisCancer Immunology, Immunotherapy, 2013
- Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell FunctionalityCancer Research, 2013
- Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic reviewBMC Public Health, 2013
- Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinomaHepatology, 2012
- Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncologyCancer Immunology, Immunotherapy, 2012
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009
- A New Population of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Induces CD4+CD25+Foxp3+ T CellsGastroenterology, 2008
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007